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Cirrhosis is a complex disease that is associated with disturbances in different organs besides the liver, including kid-
neys, heart, arterial circulation, lungs, gut, and brain. As a consequence, patients develop a number of complications 
that result in frequent hospital admissions and high morbidity and mortality. Patients with cirrhosis require constant 
and rigorous monitoring both in and outside the hospital. In this context, the role of nurses in the care of patients 
with cirrhosis has not been sufficiently emphasized and there is very limited information about nursing care of patients 
with cirrhosis compared with other chronic diseases. The current article provides a review of nursing care for the dif-
ferent complications of patients with cirrhosis. Nurses with specific knowledge on liver diseases should be incorporated 
into multidisciplinary teams managing patients with cirrhosis, both inpatient and outpatient. Conclusion: Nurses play an 
important role in the management and prevention of complications of the disease and improvement in patients’ quality 
of life and bridge the gap between clinicians and families, between primary care and hospital care, and provide medical 
education to patients and caregivers. (Hepatology 2020;71:1106-1116).
Cirrhosis is common and is the twelfth-leading cause of death worldwide.(1) In most cases, cir-rhosis is due to one of the following etiological 
factors or a combination of hepatitis C or B infection, 
excessive alcohol consumption, and nonalcoholic fatty 
liver disease (NAFLD), the latter usually associated 
with obesity and diabetes mellitus. These factors may 
lead to unrelenting fibrosis with formation of scars that 
progressively disrupt the normal liver architecture and 
function, eventually leading to cirrhosis unless the cause 
of injury is removed (e.g., elimination of hepatitis C 
virus by antiviral drugs).(2) Once established, if the cause 
is not removed, cirrhosis may progress to severe com-
plications, which negatively affect patient health- related 
quality of life. Cirrhosis is a major cause of years of life 
lost and hospital readmissions, and ultimately leads to 
death unless liver transplantation is performed.(2) In 
Europe and the United States, cirrhosis is responsible 
for approximately 170,000 and 50,000 deaths per year, 
respectively.(3,4) Because the prevalence of chronic liver 
diseases, particularly NAFLD, is increasing markedly 
worldwide, it is likely that burden related to cirrhosis 
will increase in the next few decades, even though con-
trol of hepatitis B and C will favorably affect the epide-
miology of liver disease.
Despite the global burden of cirrhosis, much less 
attention has been paid to nursing care of patients 
with cirrhosis compared to other chronic diseases.(5) 
Moreover, nursing training in liver diseases has been 
remarkably limited compared with training in other 
specialties. Incorporation of nurses into multidis-
ciplinary teams for hospital care of patients with 
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cirrhosis has been insufficient in comparison with 
other chronic conditions, particularly diabetes, cardio-
vascular diseases, and neurological diseases.(6)
With this background, a meeting was organized by 
LiverHope, with the objective of standardizing nursing 
care for patients with cirrhosis. LiverHope is a seven-na-
tion consortium consisting of nine European hospitals 
with extensive experience in hepatology that is aimed 
at exploring new therapies for cirrhosis.(7) The consor-
tium includes hepatologists and nurses with expertise in 
the management of patients with liver diseases and an 
external advisory board, and is funded by the European 
Commission under the Horizon 20/20 program. 
Within the consortium, patients are represented by the 
European Liver Patients Association (ELPA). The task 
forces to develop the consensus nursing guidelines were 
divided into the following areas of care: general care, 
ascites/edema, gastrointestinal bleeding, hepatic enceph-
alopathy, bacterial infections, acute kidney injury, and 
quality of life and stigmatization. The team of nurses 
from the different hospitals worked in groups of 2, and 
each group was assigned one or two different areas. An 
extensive review of the literature in different databases, 
including Pubmed and Cinahl, was performed. After 
literature review, documents of the different parts were 
drafted and subsequently put together and discussed 
broadly afterward. Input was also obtained from ELPA 
and experts from the United States. The final document 
is organized into sections related to main complications 
of cirrhosis. Each section has an introductory portion 
that discusses briefly, as background, the pathogenesis of 
each complication and rational basis of nursing care, fol-
lowed by proposed recommendations for inpatient care 
as well as outpatient care.
geNeRal CaRe
There are two broad stages of cirrhosis. In the 
first stage, known as compensated cirrhosis, patients 
have not yet developed complications of the disease, 
whereas in the second stage, known as decompensated 
cirrhosis, they have developed complications primar-
ily related to portal hypertension or liver failure such 
as ascites, variceal hemorrhage, jaundice, and hepatic 
encephalopathy.(8,9) From the nursing care perspec-
tive, this classification into two stages is very useful, as 
approach to care is markedly different.
Compensated Cirrhosis
Patients with compensated cirrhosis are generally 
without obvious signs of liver disease and do not have 
significant health issues related to their liver disease. 
However, they usually have comorbidities associated 
with the etiology of cirrhosis. Specifically, in patients 
with alcohol-associated cirrhosis, a major issue is the 
management of the underlying alcohol use disorder. 
The objective in these patients is achieving absti-
nence, which improves patient survival.(10,11) Although 
alcohol use disorder is managed by specialized teams, 
concerted efforts are of utmost importance. The nurse 
specialist in liver diseases provides coordination of care, 
support, and guidance to the patient not only during 
the initial phase of addiction treatment but also during 
follow-up, so that sustained sobriety can be achieved. 
In patients with nonalcoholic steatohepatitis (NASH)-
related cirrhosis, associated comorbidities are common, 
particularly obesity, diabetes mellitus, arterial hyperten-
sion, kidney dysfunction, and hyperlipidemia.(12,13) The 
objectives of the nursing role for these patients are to 
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help with management and follow-up of these comor-
bidities and suggest specialized consultations whenever 
needed. Assessment of cardiovascular risk followed by 
specific recommendations on how to reduce risks is 
of key importance. Nurses should also pay particular 
attention to specific aspects that are important in the 
follow-up of patients with compensated cirrhosis, par-
ticularly surveillance for gastroesophageal varices and 
hepatocellular carcinoma, and immunization for hep-
atitis A and B, pneumococcal pneumonia, and influ-
enza. Nutritional counseling is also important to help 
patients maintain ideal body weight and avoid protein 
and calorie malnutrition. Nursing care should also 
include education about the complications of cirrhosis, 
prevention (if possible), and early detection through 
specific symptoms (see subsequent sections for specific 
complications). Nursing care for patients with com-
pensated cirrhosis is summarized in Table 1.
patients With Decompensated 
Cirrhosis
Patients with decompensated cirrhosis are in a more 
advanced stage of the disease and may suffer from 
several complications that are specifically discussed 
in the following sections.(2,8,9) As a general concept, 
the nursing care for patients with decompensated cir-
rhosis should include frequent follow-up for disease 
assessment, either in regular visits or through tele-
phone calls, and educational support in several aspects 
of the disease (Table 1). It is important that the main 
caregiver is present at each visit, so that major issues 
can be discussed with both the patient and the care-
giver. The most important educational aspects are 
(1) enumerating the complications of cirrhosis with 
special emphasis on how to recognize and prevent 
them, (2) increasing awareness of falls and methods 
of falls prevention in patients with risk factors, and 
(3) discussing the effects and side effects of medica-
tions and compliance issues. Moreover, in each visit or 
call, the nurse should be ready to discuss any specific 
doubts or problems the patients or caregivers have.
Nurses should have specific offices that are ideally 
located in the Hepatology outpatient area next to the 
offices of hepatologists, to facilitate interaction and 
coordination of care. Moreover, meetings should be 
held at periodic intervals between nurses and hepatol-
ogists to discuss specific cases. Finally, nurses should 
be able to interact easily with nurse coordinators of 
clinical wards and case managers.
FlUID aCCUMUlatIoN: aSCIteS 
aND eDeMa
Accumulation of fluid is the most common com-
plication of cirrhosis and is a frequent cause of seek-
ing attention, either in emergency room or in day care 
settings. Fluid accumulates in the extracellular space, 
particularly the peritoneal and pleural cavities and 
interstitial tissue of the legs, causing ascites, pleural 
effusion, and leg edema, respectively.(14,15) The inten-
sity of symptoms is related to the severity of fluid 
retention. Ascites may cause abdominal discomfort, 
pleural effusion may lead to dyspnea, and leg edema 
may impair walking capacity because of “heavy legs.” 
taBle 1. general aspects of Nursing Care in patients With 
Compensated and Decompensated Cirrhosis
Compensated Cirrhosis
General measures
Screening for gastroesophageal varices every 1-2 years in patients with no/
small varices
Screening for hepatocellular carcinoma every 6 months, usually with 
ultrasound
Screening for covert HE at every clinic visit
Assessment of cardiovascular risk in patients with NASH-related cirrhosis
Specific nursing measures
Regular follow-up with standard visits or phone calls
Support and guidance for treatment of alcohol use disorder in alcohol-
associated cirrhosis
Control and counseling of comorbidities associated with NASH, such as 
obesity, diabetes mellitus, arterial hypertension, kidney dysfunction, and/
or hyperlipidemia
Nutritional and dietary counseling, particularly in patients with alcohol and 
NASH etiologies
Nursing education of patients and caregivers regarding complications of 
cirrhosis and their early detection
Decompensated cirrhosis
General measures
Assessment of general health status
Liver and renal tests measured frequently
Assessment of candidacy for liver transplantation
Specific nursing measures
Regular follow-up with standard visits or phone calls
Standard vital signs, weight, and abdominal girth
Nutritional and dietary counseling
Compliance with diet and medications
Assessment of quality of life, frailty, sleeping habits, depression, and anxiety
Nursing education to patients and caregivers on complications of cirrhosis 
and early detection and signs of alarm, awareness and prevention of falls, 
care of fragile skin, and effects and side effects of medications
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Actually, leg edema is one of the most important fac-
tors in the impairment of health-related quality of life 
in patients with cirrhosis.(16) In addition, persistence 
of edema in the legs may lead to irreversible skin 
alterations and is a risk factor for skin infections that 
may be life-threatening.(17)
The main mechanism responsible for fluid accumu-
lation in cirrhosis is an impaired capacity to eliminate 
sodium by the kidneys.(15,16,18) In health, the kidneys 
eliminate an amount of sodium through the urine, 
which is identical to the oral intake, so that the sodium 
balance is neutral. In decompensated cirrhosis, the 
amount of sodium eliminated by the kidneys is mark-
edly reduced, owing to an activation of the sodium- 
retaining mechanisms (particularly aldosterone); 
therefore, part of the sodium taken with the diet can-
not be eliminated and is retained together with water, 
thus causing an accumulation of fluid in the extra-
cellular space. In most instances, sodium is retained 
together with water at the same concentration as in 
plasma; therefore, the sodium concentration in plasma 
does not change despite water retention. However, 
in patients with very advanced cirrhosis, more water 
is retained as compared with sodium, so that plasma 
sodium decreases and patients develop so-called dilu-
tional hyponatremia. In many patients with ascites/
edema, fluid accumulation occurs despite that glo-
merular filtration is normal or only slightly impaired. 
Thus, most patients have ascites/edema but not kidney 
failure. Nevertheless, when patients develop a reduc-
tion in glomerular filtration, this aggravates ascites/ 
edema because positive sodium balance increases due 
to the more marked impairment in sodium elimina-
tion by the kidneys.
Nursing assessment of patients With 
Cirrhosis and ascites/edema
The main roles of nurses in the assessment of 
patients with cirrhosis and ascites/edema are to eval-
uate patients’ history, check current status of ascites 
and edema, and plan future care to prevent recurrence. 
If the patient has significant lower extremity edema, 
leg wraps should be applied to prevent fluid from 
continuing to accumulate and to attempt to force the 
fluid to be re-absorbed. Leg wraps can be high-stretch 
(nonambulatory patient) or short-stretch (ambulatory 
patient). A foam or cotton wrap should be applied as 
a barrier between the patient’s skin and the leg wrap 
itself. Education should be provided to the patient’s 
caregiver about how to successfully apply leg wraps 
and what complications to monitor for at home. While 
in hospital, nursing staff assess the patient’s skin on 
their legs a minimum of 3 times per day to ensure 
that no wounds are forming and skin breakdown is 
not occurring. Any open wound is a contraindication 
to leg wrap application. Capillary refill, foot/leg/ankle 
mobility, sensation, and color should be monitored 
twice per day and as needed. As mentioned previously, 
hyponatremia is a common problem for patients with 
fluid overload. Nursing staff must become familiar 
with precautions taken for these patients, specifically 
the need for seizure precautions, although they are 
uncommon. In such situations, seizure pads should be 
placed on the patient’s bed and suction should be set 
up at the bedside.
Other key aspects for patients with ascites and/or 
edema include education of the patient and caregiver 
on a low-sodium diet, importance of adherence to 
prescribed diuretics, avoidance of nonsteroidal anti- 
inflammatory drugs (NSAIDs), periodic evaluation of 
body weight, leg wrap application, and contact with 
the nurse when alarm signs are present, particularly a 
significant increase in body weight (Table 2).
gaStRoINteStINal BleeDINg
Gastrointestinal (GI) bleeding, a common com-
plication of cirrhosis, represents a frequent cause of 
hospital admission and is associated with high mor-
bidity and mortality.(19-21) There are several possible 
lesions that may cause GI bleeding in cirrhosis, most 
of them related to portal hypertension. GI bleeding 
is usually classified as upper or lower, according to 
whether the lesion responsible for bleeding is located 
above or below the angle of Treitz, respectively. The 
main causes of upper GI bleeding include gastric or 
esophageal varices and portal-hypertensive gastropa-
thy, whereas those of lower GI bleeding include rectal 
varices and portal-hypertensive enteropathy or colop-
athy. Upper GI bleeding manifests as melena and/or 
hematemesis, whereas lower GI bleeding manifests 
as hematochezia. Although hematemesis and hemo-
chezia are easily recognizable and usually prompt 
the patient to the emergency room, melena may not 
always be recognized as bleeding by some patients. As 
such, they may not seek attention immediately and 
treatment may be delayed. Symptoms of GI bleeding 
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depend on the amount of blood loss and usually 
involve dizziness, lightheadedness, profuse sweating, 
loss of consciousness, and in most severe cases, hypo-
volemic shock. The severity of symptoms depends 
on various factors, particularly patient’s age, rapidity 
of blood loss, and associated comorbidities. Supine 
tachycardia is specific for blood loss of 500-1,000 mL, 
but not sensitive. Postural tachycardia of more than 30 
beats/minute and inability to stand due to dizziness 
represents blood loss of approximately 1,000  mL. In 
addition to symptoms related to depletion of intra-
vascular volume, GI bleeding may induce hepatic 
encephalopathy (HE), because absorption of blood 
and associated proteins in the gut is similar to intake 
of a large protein load. Importantly, some patients may 
develop symptoms of HE before the loss of blood has 
been recognized. Finally, portal hypertension–related 
GI bleeding has a high probability of recurrence unless 
measures to reduce its risk are established.
Nursing assessment of patients With 
Cirrhosis and gI Bleeding
Inpatient nursing care of patients with cirrhosis 
and GI bleeding includes vital signs monitoring, par-
ticularly supine and standing blood pressure and heart 
rate, insertion of a peripheral intravenous (IV) line, and 
monitoring of mental status, skin color and tempera-
ture, and stool characteristics, among others (Table 3). 
Some patients may require a nasogastric tube to admin-
ister medications, particularly lactulose, if swallow-
ing mechanisms are not intact. It is important for the 
inpatient nurse to be aware of the degree of severity of 
esophageal varices and communicate with the physician 
taBle 2. Nursing Care of patients With Cirrhosis and ascites and/or edema
Inpatient Care
General measures
Quantify ascites/edema using 1-3 score*
Confirm patient is on low-sodium diet (< 100 mmol/day)
Start fluid restriction if hyponatremic and/or if patient is unable to use diuretics due to kidney dysfunction
Confirm monitoring of serum creatinine and electrolytes at admission and every 2-4 days
Check urine sodium in a 24-hour collection in all patients at admission and during hospitalization in those who do not lose weight
Start diuretics. Recommend large-volume paracentesis if large or tense ascites (grade 3)
Specific nursing measures
Monitor body weight and urine volume daily
Monitor edema in extremities and wrap legs as needed
Assist patient with application of an abdominal binder if umbilical hernia is present
Discuss modifications of diuretic doses with physician if weight gain, no loss of body weight, or decrease > 500 g/day for 2 consecutive days in patients 
without lower limb edema, or > 1 kg in patients with edema
Avoid bladder catheter
Avoid use of saline solutions
Monitor following paracentesis for leaks and/or infection from puncture sites
If the site is leaking, assist the patient with application of a wafer/urostomy bag to collect any leaking fluid. This way, the fluid can be measured and 
recorded. Moreover, if leakage is identified immediately after paracentesis, patient should be asked to lie on the opposite side for a few hours.
Repeat paracentesis is often required.
Monitor arterial blood pressure after large-volume paracentesis initially every 15 minutes for 2 hours and then every 30 minutes for a further 2 hours
Administer 25% albumin as ordered during or following large-volume paracentesis
Outpatient care
Specific nursing measures
Educate patients and caregivers on low-sodium diet and alternatives to salt
Educate on how to monitor body weight and consult when body weight increases > 500 g/day for at least 3 consecutive days
Explain the use of diuretics and their possible side effects
Explain that NSAIDs (e.g., aspirin, ibuprofen) must be avoided and educate on alternative painkillers
Educate on the care of skin in edematous legs
Nutrition counseling. Request a nutritional consultation in malnourished patients or patients with poor response to diuretics
*Ascites: 1, only identifiable with ultrasound; 2, moderate; 3, large or tense. Edema: 1, mild; 2, moderate; 3, large.
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to determine whether placement of a nasogastric tube 
is the safest option. The presence of esophageal and 
gastric varices can occasionally make a usually safe 
procedure quite dangerous. The risk of triggering the 
rupture of esophagogastric varices with the insertion of 
a nasogastric tube is difficult to appreciate and therefore 
unknown but likely small. It should not prevent from 
performing the procedure when indicated. Vigorous 
volume resuscitation may be associated with the devel-
opment of ascites and recurrence of bleeding, and 
therefore should be avoided unless features of hypovo-
lemia (and particularly hypovolemic shock) are present. 
Outpatient nursing care primarily involves education 
on how to identify bleeding early and ensuring compli-
ance with methods to prevent bleeding (variceal band 
ligation or beta-blockers) (Table 3).
HepatIC eNCepHalopatHy
HE is characterized by neuropsychiatric symptoms 
including disorientation, inappropriate behavior, sleep 
disturbances, abnormalities in speech, and alterations 
in consciousness that may progress to coma.(22,23) 
In the most common form of HE, known as “overt 
HE,” symptoms may appear rapidly, in a matter of 
hours, are frequently related to a precipitating fac-
tor, and resolve spontaneously or with treatment. In 
some patients, however, symptoms are constant, not 
related to a precipitating factor, and do not disappear 
with therapy. This form is known as “persistent HE.” 
Finally, there is a third form, known as “covert HE,” 
in which patients have only subtle alterations in their 
mental status, but sufficient to alter certain activities 
that require great attention, such as intellectual activi-
ties or driving a vehicle.
HE occurs because substances present in the gut 
with the capacity to interfere with neuronal func-
tion, such as ammonia, bypass the liver and reach 
the brain due to the presence of shunts between the 
portal territory and systemic circulation, and hepatic 
dysfunction.(22,23) HE commonly occurs as a result of 
a precipitating event, particularly bacterial infections, 
GI bleeding, or acute kidney injury, which cause a 
further impairment in already impaired brain func-
tion associated with advanced cirrhosis. HE is very 
common in patients with advanced cirrhosis and is 
one of the most dreaded complications, because neu-
ropsychological alterations impact very negatively on 
patients’ quality of life, and because the occurrence of 
HE bears very poor prognostic significance. Moreover, 
recurrence of overt HE is frequent and represents a 
major cause of hospital admission and readmission. 
Consequently, HE represents a heavy burden to the 
caregivers and families.
Nursing assessment of patients With 
Cirrhosis and He
Nursing care of patients hospitalized with HE 
includes evaluation of mental status, prevention of 
aspiration pneumonia, assessment of potential trig-
gers of HE (particularly bacterial infections and GI 
bleeding), nutritional support, prevention of skin 
breakdown, and bowel cleansing. Proper administra-
tion of medications to control HE (including those 
that reduce ammonia buildup in the body) is key for 




Intravenous saline for volume resuscitation and red blood count transfusions 
if hemoglobin < 7 g/dL. Dextrose solutions preferred to saline  
solutions for initial resuscitation in patients with ascites or edema
Check blood tests, particularly hemoglobin, regularly
Check for possible infections (e.g., skin, urine, lungs, ascites)
Start oral or rectal lactulose or enemas to prevent hepatic encephalopathy
Nutrition support
Specific nursing measures
Insert large-bore peripheral IV (16-18 gauge)
Monitor vital signs, including EKG, arterial pressure, and heart rate
Evaluate mental status periodically
Monitor urine volume daily, usually by collection of spontaneous voiding. 
Bladder catheter may be useful in hemodynamically unstable patients
Monitor skin pallor and temperature
Monitor characteristics of emesis or stool if blood is present (black vs. bright 
red)




Confirm all patients have an upper GI endoscopy at diagnosis of cirrhosis 
and at least every 2 years afterward, to check for presence and size of 
gastroesophageal varices
Confirm compliance with measures to prevent bleeding, either variceal band 
ligation or beta-blocker therapy
Specific nursing measures
Assess patients on beta-blocker therapy for an adequate beta-blocker effect 
(i.e., reduction in baseline heart rate of 25% to a value of approximately 
55-60 bpm)
Educate patients and caregivers on how to identify GI bleeding, particularly 
the presence of melena, and how to monitor arterial pressure and heart 
rate regularly at home
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these patients. Parameters should be identified by the 
physician for the number of stools a patient should 
have per day. Extremely accurate intake and outputs 
should be recorded for these patients, as it is a sen-
sitive balancing act to maintain adequate hydration 
while we are deliberately causing frequent, and often 
very loose stools with medications. A physician may 
require a patient to have 3-4 large, semiformed bowel 
movements per day. The inpatient nurse should rec-
ognize that this is both a limit and a requirement for 
the patient. If the patient’s HE is still significant after 
the required number of bowel movements, the physi-
cian should be notified. Patients with HE should be 
reoriented to time, place, and person frequently. They 
should be encouraged to stay awake during the day 
and remain active so they can sleep at night. If they 
are impulsive, unable to safely call for help, or are 
picking at their lines, it is important for nursing staff 
to recognize the need for an individual assignment. 
This is when a personal care assistant sits in the room 
with the patient at all times to redirect them and to 
keep them safe. In countries or hospitals where this 
type of assistant is not available, one caregiver can be 
instructed to help in this situation. Accurate calorie 
counts and collaboration with dieticians is crucial to 
keep these patients free from malnutrition; constant 
reminders and assistance with eating may be required. 
Twice-per-day skin checks on pressure points should 
be completed to ensure that no wounds or pressure 
injuries are forming. For semicomatose or comatose 
patients, prevention of skin breakdown should include 
frequent repositioning and prophylactic skin barri-
ers. These patients will likely have fragile skin due to 
nutritional deficiencies and muscle wasting with bone 
prominences; the inpatient nurse should use skin care 
products that are gentle, always prep the skin for tape/
adhesive, and assess for wounds such as skin tears and 
treat appropriately. For outpatients, the main aspects 
of nursing care are to evaluate possible existence of 
covert HE and educate patients with previous HE 
and their respective caregivers on prevention of recur-
rence and early identification of HE (Table 4).
BaCteRIal INFeCtIoNS
Bacterial infections are a potentially life-threatening 
complication of cirrhosis. The most common types of 
infections seen in patients with cirrhosis are urinary 
tract infections, respiratory infections, particularly 
pneumonia, and skin infections that usually occur in 
the legs when edema is present. Of note, skin infec-
tion may occur in other areas as well. Other infections 
include sepsis without specific focus of infection, and 
infection of the ascitic fluid, the so-called spontaneous 
bacterial peritonitis.(15,18,24) Mechanisms responsible 
for the high risk of infections in patients with cir-
rhosis include impairment in immune function that 
involves macrophages, lymphocytes, and polymor-
phonuclear cells. In many instances, bacteria causing 
the infection arise from the patient’s own microbiota, 
particularly from the gut. For this reason, infections 
may occur when patients are at home (community 
acquired), in the hospital (nosocomial), or within 
weeks and months after leaving the hospital (health 
taBle 4. Nursing Care of patients With Cirrhosis and He
Inpatient Care
General measures
Intravenous dextrose solutions should be preferred to saline solutions, 
particularly in patients with ascites and edema
Use lactulose or lactitol to produce 3-4 bowel movements/day. If there are 
no bowel movements, consider cleansing enemas
Protect airway patency. Use Mayo tube (or similar) in patients with grade 
3 HE. Patients in deep coma (grade 4) should be in intensive care and 
intubated
Nasogastric tube may be useful to aspirate gastric fluid if there is delayed 
gastric emptying, particularly in grade 3 and 4 HE
Nutrition support, particularly in patients with grade 2 or greater for more 
than 1 day
Check for possible infections (e.g., skin, urine, lungs, ascites)
Check blood tests regularly
Specific nursing measures
Insert a large-bore peripheral IV (18-20 gauge)
Monitor vital signs, including EKG, arterial pressure, heart rate
Monitor mental status
Aspirate nasopharyngeal and tracheal secretions in patients with grade 3 
or greater
Use preventive measures for skin breakdown and pressure ulcers, especially 
in fragile and malnourished patients
Monitor urine volume daily. Avoid use of bladder catheter unless patient is 
incontinent and skin breakdown is present or the patient has a severe AKI, 
in which case exact intake and outputs are needed
Outpatient Care
Evaluate presence of covert HE at every clinic visit in all patients
Education about nutrition and general care to patients’ caregivers
Request a nutritional consultation in all patients with previous HE
Education about bowel movements and use of laxatives in all patients, 
particularly those with previous HE
Evaluate quality-of-life status at least once a year in all patients with previous 
HE and their caregivers
Assess the frailty index at least once a year in all patients with previous HE
Assess the burden of disease in caregivers by using Zarit test or similar
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care associated). Nosocomial infections are associated 
with invasive procedures, such as IV catheters, bladder 
catheters, or tracheal intubation. C diff icile infection 
may also occur. Because the impairment of immune 
function tends to progress with time, bacterial infec-
tions usually recur and are a major cause of hospital 
admissions and readmissions. Of particular concern is 
the increasing prevalence of multidrug-resistant bacte-
rial infections worldwide in patients with cirrhosis.(25) 
Infections in cirrhosis may trigger complications of 
cirrhosis, primarily HE, GI bleeding, and acute kid-
ney injury (AKI).
Nursing assessment of patients With 
Bacterial Infections
The most important aspect of nursing care of 
patients hospitalized with bacterial infections involves 
prevention of infection, especially in patients with HE 
or leg edema, monitoring for signs of infections, early 
identification of possible complications of the disease, 
development of signs of systemic inflammatory response 
syndrome or sepsis, minimizing invasive procedures as 
much as possible, and antibiotic administration. The 
inpatient nurse should collaborate with the case man-
ager or social worker to determine the most appropri-
ate outpatient plan for antibiotic management (home 
health care for home infusions vs. infusion therapy cen-
ter). From there, coordination of care will be required to 
ensure the patient has the appropriate resources to be 
able to be dismissed from the hospital. Education should 
be provided about central line care and maintenance if 
the patient requires a peripherally inserted central cath-
eter line or other type of line following dismissal. If the 
infection involves a wound, collaboration with the unit’s 
clinical nurse specialist and wound therapy will be cru-
cial to ensure healing. Outpatient nursing care is related 
primarily to use of preventive measures against infec-
tions and patient and caregiver education on prevention 
and early identification of infections (Table 5).
aCUte KIDNey INJURy
AKI, previously known as acute renal failure or 
acute renal insufficiency, represents an abrupt decrease 
in glomerular filtration rate (GFR), the main function 
of the kidney.(14,15,26) AKI is common in patients with 
decompensated cirrhosis, particularly after occurrence 
of ascites. AKI may develop when patients are at home 
in apparently stable condition or in hospital admit-
ted for other complications of cirrhosis. AKI usually 
occurs as a result of a precipitating event, particu-
larly bacterial infections or acute volume loss (i.e., GI 
bleeding), which cause a further deterioration in the 
already impaired circulatory function characteristic of 
advanced cirrhosis. Patients or caregivers may identify 
AKI when they notice a reduction in the amount of 
urine eliminated; however, it is important to note that 
in many cases of AKI, at least in early stages, urine 
volume may be normal, while oliguria is only pres-
ent in more severe cases. Patients with AKI may have 
nonspecific symptoms such as feeling unwell, but may 
also develop signs of HE.
Diagnosis of AKI is made by demonstration of 
increase in serum creatinine concentration equal 
to or greater than 0.3  mg/dL (31  µmol/L) that has 
occurred within a short period of time, usually fewer 
than 7  days. However, because most patients who 
are at home may not have a recent determination of 
serum creatinine, values within the previous 3 months 




Start IV antibiotic therapy as early as possible after prescription
Avoid using central IV line unless there are specific indications for its use
Use prophylactic lactulose or lactitol to have 3-4 bowel movements/day. If 
there are no bowel movements, consider cleansing enemas
Measures to prevent nosocomial infections
Specific nursing measures
Insert an IV line; central access may be necessary if the patient is going to 
be dismissed from the hospital on IV antibiotics
Provide education about central line care, signs and symptoms of infection, 
and potential complications
Monitor signs of infection frequently (e.g., body temperature, heart rate)
Daily urine collection is important to identify oliguria promptly. Instruct 
patient/caregivers to collect urine by spontaneous voiding. Avoid using 
urinary bladder catheters, except in hemodynamically unstable, intubated 
patients or patients with severe AKI
Measure arterial pressure frequently. In very ill patients, arterial pressure 
should be monitored at very short intervals
Report any significant decrease in mean arterial pressure of greater than 
10 mm Hg. Be aware that patients with advanced cirrhosis are usually hy-
potensive, and reductions in arterial pressure may be difficult to recognize
Outpatient Care
Educate patients and caregivers on early identification of signs of infection 
(particularly fever, abdominal pain, initial signs of HE, dysuria, and/or res-
piratory symptoms). Patients with these symptoms should get in contact 
with their nurse for advice or, if not possible, go to the emergency room
Check if patients have indications for prophylactic antibiotic therapy and 
consult with their physician about its use
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can be used as baseline.(15) The most common causes 
of AKI are (1) hypovolemia due to volume loss sec-
ondary to bleeding (usually from GI tract) or exces-
sive losses by urine or diarrhea; (2) acute tubular 
necrosis, a severe form of AKI usually associated with 
shock; and (3) hepatorenal syndrome (HRS). HRS is 
a type of AKI, known as AKI-HRS with the current 
terminology, that is unique to patients with cirrho-
sis and is characterized by very intense reduction of 
GFR that occurs in the absence of volume losses and 
significant light-microscopic abnormalities in kidney 
histology.(14) Although less frequent, AKI may also 
occur as a result of NSAIDs that are prescribed for 
treatment of pain. NSAIDs cause inhibition of pros-
taglandin synthesis in the kidney, which may lead to 
AKI in decompensated cirrhosis. This type of AKI 
may be severe and progress despite withdrawal of the 
drug, and has a high mortality rate.
Nursing assessment of patients With 
aKI
Nursing care of patients hospitalized with AKI 
involves monitoring of urine volume and characteris-
tics, serum creatinine and electrolytes, early identifica-
tion of potential associated complications, particularly 
HE, and early detection of signs of metabolic acidosis 
and cardiopulmonary congestion. Monitoring of vol-
ume of fluid losses is important in all patients hospi-
talized, as volume losses from variceal bleed, aggressive 
diuresis, and diarrhea with administration of lactu-
lose can all contribute to AKI. As previously men-
tioned, fluid restriction may be required for patients 
with fluid volume overload and/or hyponatremia. It 
is important for nursing to collaborate with physi-
cians to ensure appropriate fluid intake, while keeping 
the patient safe from becoming too fluid volume– 
overloaded. Adequate hydration is important during 
AKI and the inpatient nurse is faced with another 
balancing act to maintain hydration but prevent-
ing ascites or edema (including pulmonary edema) 
from getting out of hand. The inpatient nurse should 
become familiar with interventions for hyperkalemia, 
as this is a dangerous complication of AKI. These 
interventions should be carried out in a timely man-
ner once the physician orders them. If a patient is 
hyperkalemic, the inpatient nurse should assess the 
patient’s heart sounds, listen for any irregularities, and 
report them promptly to the physician and perform an 
electrocardiogram (EKG). If the patient is undergoing 
EKG monitoring, the presence of peaked T waves, PR 
prolongation, QRS widening, and disappearance of P 
waves raises the question of hyperkalemia. If hyper-
kalemia is noted during the hospitalization, discus-
sion with the dietician is crucial to assist in education 
on a low-potassium diet. Hyperkalemic emergencies 
may require intravenous administration of calcium, 
glucose, insulin and bicarbonate, and constant EKG 
monitoring as emergency treatment. Outpatient care 
is related primarily to nursing education about use of 
drugs such as diuretics or laxatives, and avoidance of 
NSAIDs (Table 6).
QUalIty oF lIFe aND SoCIal 
ISSUeS
Health-related quality of life in both mental as 
well as physical components is frequently impaired in 
patients with cirrhosis, particularly in patients with 
decompensated cirrhosis.(16,27,28) The impairment in 
quality of life is related to several factors, particularly 
ascites, HE, leg edema, muscle cramps, insomnia, and 
low serum sodium concentration. In addition, untow-
ard effects of treatments, associated conditions and 
their therapy, and general anxiety generated by concern 
taBle 6. Nursing Care of patients With aKI
Inpatient Care
General measures
Serum creatinine and electrolytes should be measured daily; more often if 
hyperkalemia is present
Administration of large amounts of IV fluids should be avoided, except in 
patients in whom AKI is due to volume depletion
IV saline solutions should be avoided, except in patients in whom AKI is due 
to dehydration; consider IV albumin replacement
Evaluate possible candidacy for liver transplantation
Specific nursing measures
Insert a short peripheral IV line (18-20 gauge); a large catheter may be 
needed in some patients
Monitor vital signs frequently
Monitor urine volume. Use of bladder catheter should be considered, as 
strict monitoring is necessary in these patients. Take measures to prevent 
urinary tract infections
Be ready for early identification of symptoms of HE
Look for signs or symptoms of bacterial infections
Outpatient Care
Educate patients and caregivers on early identification of signs of AKI, 
particularly reduction in urine volume. Patients with oliguria should get in 
contact with their nurse for advice
Educate patients and caregivers on early identification of HE, which may be 
the first sign of AKI
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for disease outcome contribute to the alteration of 
the quality of life. Nurses should evaluate quality- 
of-life status regularly and educate patients on how 
to cope with more impaired aspects and prevent com-
plications, particularly falls. Factors associated with an 
increased risk of falls are covert or overt HE and low 
serum sodium concentration.(16,29) Therefore, preven-
tive measures should be taken particularly in patients 
with risk factors for falls.
Finally, patients with cirrhosis may suffer from 
social stigmatization, as they are usually perceived to 
have an alcohol use disorder even if they have other 
etiologies of cirrhosis. This may lead to impairment 
in quality of life and have a negative effect on self- 
esteem, personal management, and ability to cope with 
the disease.(30) Accordingly, nurses have an important 
role in the detection of the impact that stigmatization 
may have on their patients and seeking solutions to 
avoid harmful effects.
CoMMeNtS FRoM patIeNtS
The ELPA is well aware of the complexity and 
severity of cirrhosis, and one of its main objectives is 
help improve the management and quality of life of 
patients with cirrhosis. In this regard, ELPA enthu-
siastically supports a greater involvement of nurses in 
the care of patients with cirrhosis. Nurses should play 
a major role in the education of patients and caregiv-
ers by devoting a greater length of time to patient care 
compared to that of physicians and other health care 
professionals, thus improving patients’ quality of life 
and reducing the burden on health care systems.
Conclusions and Future 
Directions
Cirrhosis is a very frequent and devastating dis-
ease, as patients have a high number of complica-
tions, marked impairment in quality of life, frequent 
hospitalizations, and high mortality. In this context, 
nursing care to both hospitalized and nonhospital-
ized patients is of utmost importance to help manage 
and prevent complications of the disease and improve 
quality of life. Nurses play a pivotal role in the care of 
patients with cirrhosis not only by bridging the gaps 
between clinicians and families and between primary 
and hospital care, but also by providing medical edu-
cation to patients and caregivers. Despite the extreme 
importance of cirrhosis as a global disease, very little 
attention has been paid to the role of nurses by health 
and hospital authorities, national and international 
colleges of nurses, and national and international 
nursing or hepatology societies. In very recent years 
there have been some small movements to improve 
this situation, particularly after the first report of the 
UK Liver Lancet Commission,(31) but much remains 
to be done. Health and hospital authorities should 
stimulate the creation of positions of nurse liver spe-
cialists dedicated to caring for patients with cirrhosis. 
In the past, most liver nurse specialists were devoted 
to care of patients with hepatitis C or B infection or 
liver transplantation, but not to patients with compli-
cations of cirrhosis. This situation should be changed 
and multidisciplinary teams in all hospitals caring 
for patients with cirrhosis should include nurse liver 
specialists with special education in cirrhosis. In 
this regard, both national and international societies 
should develop education plans at the nurse practi-
tioner or master level to fill this gap in education.
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